@article{b480eb971f6248d6b4f36f9e11e49fff,
title = "Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial",
abstract = "The aim of the study was to compare changes in bone mineral density (BMD) over 144 weeks in HIV-infected patients initiating nucleoside reverse transcriptase inhibitor (NRTI)-sparing or protease inhibitor-sparing highly active antiretroviral therapy (HAART).",
keywords = "Absorptiometry, Photon, Adult, Antiretroviral Therapy, Highly Active, Benzoxazines, Bone Density, Female, HIV Infections, HIV-1, Humans, Lamivudine, Male, Pyrimidinones, Ritonavir, Zidovudine",
author = "Hansen, {Ann-Brit Eg} and N Obel and H Nielsen and C Pedersen and J Gerstoft",
note = "{\textcopyright} 2010 British HIV Association.",
year = "2011",
month = mar,
day = "1",
doi = "10.1111/j.1468-1293.2010.00864.x",
language = "English",
volume = "12",
pages = "157--65",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",
}